Eloxx Pharmaceuticals Inc
Biotechnology
Healthcare
ELOX
88.49 M shares
NASDAQ US
traded
13 Oct 2023
listed
yes
open
4.05
52 week high
10.90
high
4.29
52 week low
1.33
low
3.79
growth
-7.51 %
previous Close
4.05
P/E ratio
-2
market cap
11.89 M
div yield
0
usd
Jun 2023
qoq
revenue
0.00 %
net incoming
-4.34 M
37.78 %
eps
-1.96 %
32.88 %
eps surprise
-27.27 %
net profit margin
-434100000.00 %
0.00 %
operating incoming
-4.14 M
24.49 %
net change in cash
-624.00 K
95.64 %
cash on hand
4.33 M
-11.68 %
cost of revenue
0.00 %
top top